On February 7, 2024 Ascendis Pharma A/S (Nasdaq: ASND) reported that company executives will participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference (Press release, Ascendis Pharma, FEB 7, 2024, View Source [SID1234639903]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details:
Event Oppenheimer 34th Annual Healthcare Life Sciences Conference
Location Virtual
Date Tuesday, February 13, 2024
Time 4:00 p.m. Eastern Time / 1:00 p.m. Pacific Time
A live webcast of the event will be available via the Investors & News section of the Ascendis Pharma website at investors.ascendispharma.com. A webcast replay will also be available on this website shortly after conclusion of the event for 30 days.